Katrien Poelaert | Senior Scientist
Ziphius NV

Katrien Poelaert, Senior Scientist, Ziphius NV

Dr. Katrien Poelaert is a veterinarian by training and obtained her PhD in Veterinary Sciences in 2019 at the Laboratory of Virology, Faculty of Veterinary Medicine (Ghent University, Belgium) under the supervision of Prof. Nauwynck, focussing on the pathogenesis of equine herpes viruses. She was granted a fellowship of the Belgian American Educational Foundation (BAEF) to start a post-doctoral research project at Fox Chase Cancer Center (Philadelphia, Temple University, USA) focusing on measles virus spread and dormancy in the central nervous system. After this stay in the USA, she joined the research group of Prof. van Kuppeveld at Utrecht University (The Netherlands) to study the neuropathogenesis of non-polio enteroviruses (Enterovirus D68). In October 2021, she joined Ziphius (Zwijnaarde, Belgium), a biotech company focused on saRNA technology, where she holds a position as Senior Scientist and head of the Preclinical Department

Appearances:



Day 2 - Wednesday 15th October @ 11:40

Self-amplifying mRNA vaccination elicits protection in the upper and lower respiratory tract of naïve non-human primates 6 months after first immunization

Session led by: Ziphius NV

Day 2 - Wednesday 15th October @ 11:40

Self-amplifying mRNA vaccination elicits protection in the upper and lower respiratory tract of naïve non-human primates 6 months after first immunization

Session led by: Ziphius NV
last published: 16/Sep/25 16:05 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.